La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Kane Biotech a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Kane Biotech..

Kane Biotech (OTC:KNBIF) Azioni, Catena delle Opzioni

Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The Company has a separate operating segment for its Stem Animal Health subsidiary, which operates the animal health business. The firm is also engaged in the animal health business through its Stem Animal Health subsidiary.

KANE BIOTECH INC ORD by Kane Biotech Inc.

Kane Biotech Inc

Kane Biotech GAAP EPS of -$0.01, revenue of $0.72M

Kane Biotech enters into agreement to amend its credit facility

Kane Biotech GAAP EPS of -$0.01

Kane Biotech GAAP EPS of -$0.01, revenue of $0.94M

Kane Biotech signs license deal with Omni Bioceutical for its scalp care products

Kane Biotech GAAP EPS of $0.07, revenue of $810.3M

KNBIF

Press Releases

Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve™ Antimicrobial Wound Gel

Kane Biotech to Release Second Quarter 2024 Financial Results on August 29, 2024 – Conference Call to Follow

General

Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel

Health Care

Kane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations

Earnings

Kane Biotech Announces Second Quarter 2024 Financial Results

News

Financing

Kane Biotech Announces Exercise of Warrants

Kane Biotech Announces Attendance at Upcoming Wound Care Conferences

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine

TSXV:KNE

Kane Biotech

Comments

Kane Biotech

Kane Biotech (KNBIF) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO